Tsukuba, Japan

Norio Masuko



 

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 27(Granted Patents)


Location History:

  • Saitama, JP (1999)
  • Tsukuba, JP (2000 - 2018)

Company Filing History:


Years Active: 1999-2018

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Norio Masuko: Innovator in Anticancer Compounds

Introduction

Norio Masuko is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel anticancer agents. With a total of 4 patents to his name, Masuko's work has the potential to impact cancer treatment significantly.

Latest Patents

Masuko's latest patents include a piperidine compound or salt thereof, which exhibits excellent aurora A-selective inhibitory action. This compound is particularly useful as an orally administrable anticancer agent. Additionally, he has developed a novel agent aimed at potentiating the anti-tumor effects of microtubule agonists, including taxane anticancer agents. His work also encompasses combination therapies that enhance the efficacy of these treatments.

Career Highlights

Throughout his career, Norio Masuko has worked with notable companies such as Taiho Pharmaceutical Company Limited and Shell Oil Company. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.

Collaborations

Masuko has collaborated with esteemed colleagues, including Tetsuya Sugimoto and Hidekazu Takahashi. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of cancer therapies.

Conclusion

Norio Masuko's contributions to the field of anticancer research highlight his dedication to improving treatment options for patients. His innovative work continues to pave the way for future advancements in cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…